Qure's AMT-130 shows 80% Huntington's progress reduction, eyeing FDA approval. Click here to read why I rate QURE stock a Buy ...

Workers at Informa TechTarget are the latest batch of employees expected to return to the office this year following a recent ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

Presentation will include an update on the development and launch preparations of Cylembio™ (imsapepimut and etimupepimut, adjuvanted)NEW YORK, ...

A federal judge is set to hear arguments this week on the Trump administration's order to slash "indirect costs" for NIH ...

From artificial intelligence and biotech to autonomous driving, China is disrupting the traditional high-cost model of proprietary innovation Technological dominance was once synonymous with ...

Another healthcare stock came across our desk during the mid-week session after it was announced that Piper Sandler initiated ...

Cellevate AB, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing ...

Charles River Laboratories on Wednesday beat fourth-quarter profit and revenue estimates, helped by stable demand for its drug discovery and development services from biotech clients.

Swiss drugmaker Roche began a study last year of its experimental drug, RG6237, as a monotherapy in people with high body ...